QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
16.77
+0.20 (1.21%)
Jul 31, 2026, 4:00 PM EDT - Market closed
QuidelOrtho Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Revenue Revenue Growth | 2,657 | 2,730 | 2,783 | 2,998 | 3,266 | 1,699 |
Revenue Growth | -3.89% | -1.89% | -7.17% | -8.21% | 92.28% | 2.22% |
Gross Profit Gross Profit Growth | 1,195 | 1,274 | 1,287 | 1,497 | 1,936 | 1,278 |
Operating Income Operating Income Growth | -983.6 | -919.2 | -1,961 | 139.1 | 843.7 | 906 |
Net Income Net Income Growth | -1,211 | -1,132 | -2,052 | -10.1 | 548.7 | 704.2 |
Earnings Per Share EPS Growth | -17.78 | -16.72 | -30.61 | -0.15 | 9.56 | 16.43 |
EPS Growth | - | - | - | - | -41.81% | -11.67% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Labs Labs Growth | 1,486 | 1,506 | 1,427 | 1,425 | 820.2 | 44.8 |
Immunohematology Immunohematology Growth | 553.6 | 543.8 | 522 | 512.4 | 296.8 | - |
Donor Screening Donor Screening Growth | 47.6 | 52.6 | 115.1 | 136.1 | 97 | - |
Point of Care Point of Care Growth | 543.5 | 601.6 | 694.6 | 892.2 | 1,955 | 1,453 |
Molecular Diagnostics Molecular Diagnostics Growth | 26.7 | 26.5 | 24 | 31.7 | 96.7 | 200.5 |
Revenue (Total) Revenue (Total) Growth | 2,657 | 2,730 | 2,783 | 2,998 | 3,266 | 1,699 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Cash & Investments Cash & Investments Growth | 140.4 | 169.8 | 98.3 | 167.3 | 345 | 828.5 |
Total Debt Total Debt Growth | 2,843 | 2,805 | 2,650 | 2,587 | 2,825 | 129.3 |
Net Cash (Debt) Net Cash Growth | -2,703 | -2,635 | -2,552 | -2,420 | -2,480 | 699.2 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -39.69 | -38.92 | -38.06 | -36.23 | -43.20 | 16.30 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 6.6 | 105.2 | 83 | 280.2 | 885.3 | 805.9 |
Capital Expenditures CapEx Growth | -166 | -188.2 | -195.1 | -209.3 | -140.9 | -292.8 |
Free Cash Flow Free Cash Flow Growth | -159.4 | -83 | -112.1 | 70.9 | 744.4 | 513.1 |
Free Cash Flow Growth | - | - | - | -90.48% | 45.08% | -9.15% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Gross Margin | 44.96% | 46.67% | 46.23% | 49.94% | 59.28% | 75.26% |
Operating Margin | -37.02% | -33.67% | -70.46% | 4.64% | 25.83% | 53.34% |
Pretax Margin | -44.35% | -40.57% | -76.59% | -0.97% | 22.53% | 53.00% |
Profit Margin | -45.57% | -41.45% | -73.74% | -0.34% | 16.80% | 41.46% |
FCF Margin | -6.00% | -3.04% | -4.03% | 2.37% | 22.79% | 30.21% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
PE Ratio | - | - | - | - | 8.96 | 8.22 |
Forward PE | 8.97 | 13.89 | 21.58 | 14.60 | 17.67 | 14.83 |
P/FCF Ratio | - | - | - | 69.33 | 7.64 | 10.97 |
PS Ratio | 0.43 | 0.71 | 1.08 | 1.64 | 1.74 | 3.31 |